The aim of the study presented here was to determine the prevalence of Chlamydia pneumoniae versus Mycoplasma pneumoniae infections in paediatric patients with community-acquired pneumonia. A total of 50 patients (mean age, 5.5 years; median, 3.9 years) with community-acquired pneumonia were enrolled. Four patients were found to have Chlamydia pneumoniae infection (1 culture positive, 1 PCR positive and 2 serology positive) and 16 patients had Mycoplasma pneumoniae infection (2 PCR positive, 4 PCR and serology positive, 10 serology positive), including three patients with coinfection. The rates of Mycoplasma pneumoniae infection were 22%, 35% and 40% in children aged 1-3, >3-7 and >7 years, respectively. Acute Chlamydia pneumoniae infection...
Background: Atypical pneumonia caused by Mycoplasma pneumoniae is a leading cause of mortality among...
"Atypical" pneumonia was described as a distinct and mild form of community-acquired pneumonia (CAP)...
One of the challenges in planning the treatment of respiratory tract infection in children is identi...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
Background.The epidemiology of Mycoplasma pneumoniae (Mp) among US children (<18 years) hospitalized...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
One of the challenges in planning the treatment of respiratory tract infection in children is identi...
Background: Atypical pneumonia caused by Mycoplasma pneumoniae is a leading cause of mortality among...
"Atypical" pneumonia was described as a distinct and mild form of community-acquired pneumonia (CAP)...
One of the challenges in planning the treatment of respiratory tract infection in children is identi...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
In order to evaluate the role of Mycoplasma pneumoniae and Chlamydia pneumoniae, we studied 613 chil...
Background.The epidemiology of Mycoplasma pneumoniae (Mp) among US children (<18 years) hospitalized...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
Mycoplasma pneumoniae and Chlamydia spp., which are associated with community-acquired pneumonia (CA...
One of the challenges in planning the treatment of respiratory tract infection in children is identi...
Background: Atypical pneumonia caused by Mycoplasma pneumoniae is a leading cause of mortality among...
"Atypical" pneumonia was described as a distinct and mild form of community-acquired pneumonia (CAP)...
One of the challenges in planning the treatment of respiratory tract infection in children is identi...